CorVus Biomedical LLC is a subsidiary of the CorVus Foundation, and supports their continuing efforts to study treatments and therapies to treat diabetes and diabetes-related cardiovascular disease. This includes novel pharmacotherapies, surgical procedures, implanted devices and behavioral modification.
Board of Directors
James Byrd: President, Chief Operating Officer and Co-Founder.
Michael Sturek, PhD: Chief Scientific Officer, Chief Executive Officer and Co-Founder.
Mouhamad Alloosh, MD, MS: Chief Executive Officer and Co-Founder.
Rabia Jermoumi, PhD: Chief Financial Officer.